Re-induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2

Elizabeth A. Raetz, Mitchell S. Cairo, Michael J. Borowitz, Xiaomin Lu, Meenakshi Devidas, Joel M. Reid, David M. Goldenberg, William A. Wegener, Hui Zeng, James A. Whitlock, Peter C. Adamson, Stephen P. Hunger, William L. Carroll

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Re-induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2'. Together they form a unique fingerprint.

Medicine & Life Sciences